Philips connects clinicians to patients in the hospital and at home

PHILIPSAt the World Congress of Cardiology (WCC 2006) Royal Philips (NYSE: PHG, AEX: PHI) is showcasing a range of advanced technologies that enable clinicians to provide their patients with the care they need, both across the hospital and in the home. The company is introducing a new release of its integrated cardiovascular information system to the European market, as well as demonstrating the commercial release of Motiva, its interactive healthcare platform, for the first time in Europe.

Today, cardiologists are facing the challenge of a dramatic increase in the number of cardiac patients that require treatment. In response, Philips has developed patient-focused technologies that enable cardiologists to act earlier, react faster and make more accurate treatment decisions.

Connecting in the hospital
Philips is introducing a new release of its integrated cardiovascular information solution to the European market, the Philips Xcelera R2.1, which now integrates exam results from all key cardiology subspecialties - interventional cardiology, cardiovascular ultrasound, ECG, nuclear cardiology, cardiac CT, cardiac MR and electrophysiology. This advanced cardiovascular solution for documentation, viewing, quantification and reporting tasks, provides clinicians with access to relevant images and information on patients across the hospital from a single workspace.

"At Philips we recognize the key role that access to detailed patient information plays in the provision of cardiac care - whether the patient is in the hospital or at home," said Kevin Haydon, executive vice president and CEO of Philips Medical Systems Global Sales & Service International. "That's why we offer a fully integrated portfolio of medical systems that enables clinicians to deliver fast and accurate diagnosis and treatment, wherever they are, whenever they want, improving patient outcomes while reducing costs."

Connecting at home
Philips will also be demonstrating Motiva, a TV-based interactive healthcare platform that empowers patients to play a greater role in managing their own chronic conditions. Using a secure broadband connection to the home television, along with home vital sign measurement devices, Motiva enables healthcare providers to educate, motivate and communicate with patients, as well as monitor their health status remotely. Motiva engages patients daily with an automated, yet personalized, programme of healthcare content - educational video clips, interactive feedback, healthy tips and reminders -centred on evidence-based health behaviour change strategies.

"With the first commercial release of Motiva, we're bringing healthcare providers and patients closer together, extending the frontier of the hospital to the home," said Maarten Barmentlo, vice president, CEO Connected Care, Consumer Healthcare Solutions, Philips Medical Systems. "By educating patients about their condition and empowering them to help manage their own health, Motiva has the potential to benefit every healthcare stakeholder, not least the patients themselves."

Xcelera 2.1 - Connecting cardiac care
In addition to managing examination results in a patient centric-manner, the new release of Xcelera also brings a variety of new or enhanced clinical and reporting tools for 2D and 3D Echo, Cardiovascular X-Ray, Nuclear cardiology, 2D and 3D Cardiac CT and MR, as well as for managing EP recording and mapping information. The new design of results management and availability of new and enhanced clinical tools enables cardiac professionals to more efficiently diagnose a patient's condition and subsequently make more informed decisions about the method of treatment. For example, a recent study on coronary assessment conducted at sites worldwide found that 39 percent of patients evaluated who had coronary disease symptoms could have avoided catheterization, an invasive procedure, if they had been given a CT angiography exam.

The Philips Xcelera WebForum provides secure direct access to the information managed in Xcelera from both within and outside of the hospital, enabling clinicians to compare and contrast data from patients assessed in different locations or share information within their clinical community.

At the World Congress of Cardiology 2006 Philips will be showcasing a number of other products that enable clinicians to make informed decisions about a patient's cardiac condition by integrating and analyzing information from across the Critical Care Unit, interventional and non-invasive care areas. These include:

Non-interventional diagnosis products

CT TrueView Technology
This software integrates CT imaging into the catheterization lab by allowing 3D CT images to be transferred to the Philips Allura Xper FD cardiovascular X-Ray system. This provides clinicians with a more accurate view of the anatomy for the treatment planning of invasive procedures such as ischemia, arrhythmia and heart failure.

Comprehensive Cardiac Analysis (CCA)
Comprehensive Cardiac Analysis is an analysis tool designed for cardiologists, cardiac radiologists and CT technologists to perform detailed evaluation of the coronary arteries and advanced ventricular functional analysis using CT datasets. Philips substantially reduces the time and complexity of a cardiac evaluation, helping to simplify procedures and assessment for clinicians and improve diagnostic confidence.

Electrophysiology (EP Planning) Software Package
Electrophysiology measures the electrical activity of the heart which defines its pulses and rhythms. This CT study is essential when it comes to identifying the changes in electrical activity that occur during ischemia and arrhythmia and for planning ablation procedures. The EP Planning software package is designed to provide assistance in planning and assessing the impact of electrophysiology studies.

New Live 3D pediatric echo and heart failure management capabilities on the iE33 system
The new, compact X7-2 xMATRIX PureWave transducer, with a much smaller profile, provides physicians remarkable Live 3D imaging of the heart in small pediatric patients. Upgrades to QLAB quantification software provide enhanced heart failure management tools.

Interventional products

Simplifying complex procedures with EP Navigator
The Philips EP Navigator is a new tool dedicated to electrophysiology, designed to help clinicians undertake atrial fibrillation procedures, done by ablation around the pulmonary veins, in a faster and more secure way. EP doctors frequently have the feeling of "navigating in the dark". By including CT segmentation and CT/fluoro overlays, the EP Navigator offers a tool to better locate the position of the catheter within the left atrium in 3D during the procedure. The electrophysiologist loses less time and can better concentrate on the ablation itself.

Improving workflow for the Cardiac Cath Lab with Philips Series III
Series III is a solution that comprehensively integrates Haemodynamic clinical findings and diagnostic images for the Cath Lab, improving workflow and data management. This single system frees up physicians' time, not only by speeding up data entry but also by having all information in one place, making it quicker and easier to retrieve the data.

Many of these products will be featured on the Philips booth, located in Hall 2 - Booth number H250

For further information please contact:
Europe
Gert van Santen
Tel: +31 40 27 82682
This email address is being protected from spambots. You need JavaScript enabled to view it.

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is one of the world's biggest electronics companies and Europe's largest, with sales of $37.7 billion (EUR 30.4 billion) in 2005. With activities in the three interlocking domains of healthcare, lifestyle and technology and 158,000 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...